🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06236945
Recruiting Observational

HUTT to Assess Cardiac Autonomic Nervous Function

NCT06236945 · tracked via the Priya Life Science China tracker
Sponsor
The First Hospital of Hebei Medical University
Phase
Observational
Started
2024-01-31
Last updated
2024-09-26

Condition(s) studied

Autonomic Nervous System Diseases

Study summary

Autonomic nervous system diseases can cause abnormalities in the circulatory system, leading to malignant arrhythmia and sudden cardiac death. Standardized, operable, and simplified diagnostic indicators are urgently needed to evaluate autonomic nervous function, particularly cardiac autonomic nervous function. The investigators use HUTT in order to provide data support for cardiac autonomic nervous system evaluation.

Eligibility

Sex
ALL
Min age
12 Years
Max age
85 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Vertical tilt test and 24-hour holter electrocardiogram were performed at the same time * Receive treatment in our hospital. Exclusion Criteria: * Taking benzodiazepines or hypotensive drugs within 24 hours * Combined with mental illness, severe dementia, serious organ disease * Severe arrhythmia, deep breathing and poor coordination of Valsaval movements affected the interpretation of results.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The First Hospital Of Hebei Medical University Shijiazhuang Hebei Recruiting

More The First Hospital of Hebei Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06236945 on ClinicalTrials.gov ↗ ← All trials in China